1. Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease. Issue 2 (28th January 2022) Authors: Østergaard, Jakob A.; Jha, Jay C.; Sharma, Arpeeta; Dai, Aozhi; Choi, Judy S.Y.; de Haan, Judy B.; Cooper, Mark E.; Jandeleit-Dahm, Karin Journal: Clinical science Issue: Volume 136:Issue 2(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endothelin in diabetes-associated atherosclerosis: opportunity 'NOX'. Issue 4 (20th January 2021) Authors: Jandeleit-Dahm, Karin Journal: Cardiovascular research Issue: Volume 117:Issue 4(2021) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes. (March 2022) Authors: Buyadaa, Oyunchimeg; Salim, Agus; Morton, Jedidiah I.; Jandeleit-Dahm, Karin; Magliano, Dianna J.; Shaw, Jonathan E. Journal: Therapeutic advances in endocrinology and metabolism Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes. (October 2017) Authors: Ying, Ya-Lan; Chen, Yung-Chih; Jandeleit-Dahm, Karin; Peter, Karlheinz Journal: Atherosclerosis Issue: Volume 265(2017) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding. (November 2013) Authors: Stephenson, Dylan T; Jandeleit-Dahm, Karin; Balkau, Beverley; Cohen, Neale Journal: Diabetes & vascular disease research Issue: Volume 10:Number 6(2013) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ Damage. (May 2019) Authors: Elbatreek, Mahmoud H.; Pachado, Mayra P.; Cuadrado, Antonio; Jandeleit-Dahm, Karin; Schmidt, Harald H.H.W. Journal: Trends in endocrinology and metabolism Issue: Volume 30:Number 5(2019) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development. Issue 6 (24th December 2020) Authors: Thallas-Bonke, Vicki; Tan, Sih Min; Lindblom, Runa S; Snelson, Matthew; Granata, Cesare; Jha, Jay Chandra; Sourris, Karly C; Laskowski, Adrienne; Watson, Anna; Tauc, Michel; Rubera, Isabelle; Zheng, Guoping; Shah, Ajay M; Harris, David C H; Elbatreek, Mahmoud H; Kantharidis, Phillip; Cooper, Mark... Journal: Nephrology dialysis transplantation Issue: Volume 36:Issue 6(2021) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The role of Nox5 in diabetic complications. Issue 3 (May 2019) Authors: Jha, Jay C.; Kennedy, Chris; Dai, Aozhi; Cooper, Mark; Wastson, Anna; Touyz, Rhian; Jandeleit-Dahm, Karin Journal: Obesity research & clinical practice Issue: Volume 13:Issue 3(2019) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗